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SUMMARY. The purpose of the present study was to prepare spherical agglomerates (SA) of piroxicam by
solvent change method. Crystallization medium used for spherical agglomerates of piroxicam consisted of
DMF:water and chloroform. The presence of solvents residual in SA was determined by gas chromatogra-
phy and were particles were characterized by DSC, FT-IR, XRD and SEM. The respective solubility study
and dissolution behavior studies were carried out. The samples were stored in stability chamber to investi-
gate their physical stabilities. Solvents residuals in SA were found to be within the limits and exhibited de-
creased crystallinity of piroxicam in SA than pure piroxicam. The solubility and dissolution of the spheri-
cal agglomerates was improved compared with pure piroxicam and recrystallized sample. In stability test,
the release profile of the spherical agglomeration was almost unchanged as compared with the freshly pre-
pared spherical agglomeration stored at 20 °C and 45 % relative humidity for 90 days. Hence this tech-
nique can be used to obtain modified drug raw material for formulation of tablets of piroxicam by direct
compression with directly compressible tablet excipients.
